Xinqiao Hospital Of Chongqing

This study is testing whether adding a clot-busting drug (rhTNK-tPA) before standard surgical clot removal improves recovery for stroke patients who arrive at the hospital 4.5 to 24 hours after their symptoms begin. About 820 adults with a major artery blockage will be randomly a…

This study is comparing two different blood clot medications (tirofiban and alteplase) given through an IV before a standard procedure to remove a major blockage in the brain. The goal is to see which drug is safer and more effective at helping stroke patients regain independence…

This early-stage study is testing a new type of drug that uses mRNA technology, similar to some COVID-19 vaccines, to treat B-cell blood cancers like leukemia and lymphoma that have not responded to standard treatments. The drug is designed to target a protein called CD19 found o…

This study aims to find out if a simpler, more widely available type of brain scan works as well as more complex scans for deciding which stroke patients should receive a procedure to remove a blood clot. Researchers will compare outcomes for about 1,800 stroke patients who are s…